These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 5515370)

  • 21. [Trial and evaluation of a new hepatoprotector, choleretic and antispasmodic preparation].
    Fernández Navarro MD; García Pérez M; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 Oct; 38(4):503-10. PubMed ID: 4629092
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical trial of the use of a drug combination in gastroenterology].
    Nizzo MC; Mavilio R; Lepore R
    Clin Ter; 1978 Mar; 84(5):491-500. PubMed ID: 348384
    [No Abstract]   [Full Text] [Related]  

  • 23. The condition of the biliary tract and cholesecretion in cases of ulcerative colitis.
    Abasov IT; Isaev EG; Iof IM
    Hepatogastroenterology; 1985 Jun; 32(3):138-40. PubMed ID: 4018708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative evaluation of the therapeutic effect of pequocrin and allochol in chronic cholecystocholangitis].
    Tsimmerman IaS; Mezheborskiĭ AM
    Vrach Delo; 1976; (5):77-82. PubMed ID: 969428
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of Cholipin on bile formation and secretion, its therapeutic spectrum].
    Andrejević M; Stanković S
    Med Glas; 1968 Nov; 22(11):389-91. PubMed ID: 5200353
    [No Abstract]   [Full Text] [Related]  

  • 26. [Correction of vitamin deficiency in chronic biliary tract diseases during health resort treatment].
    Podorozhnyĭ PG; Kushnir VV
    Vrach Delo; 1981 Oct; (10):67-9. PubMed ID: 7303583
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modern approaches to the treatment of biliary pathology in young patients with obesity].
    Khismatullina GIa; Volevach LV; Khakamova GA; Uliamaeva VV; Bychenkova MA
    Eksp Klin Gastroenterol; 2012; (4):60-5. PubMed ID: 23402156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical observations on the therapeutic activity of the preparation mendiaxon in diseases of the biliary tract].
    Ivanov S; Matinheva R; Kostova N
    Vutr Boles; 1982; 21(3):17-21. PubMed ID: 7113181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and complex treatment of dyskinesis of the biliary tract].
    Galkin VA; Belaia NA; Lebedeva IP; Iurkova TD
    Ter Arkh; 1974; 46(10):31-5. PubMed ID: 4215169
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of diseases of the gallbladder and bile ducts].
    Basarab A
    Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1608-12. PubMed ID: 4647608
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of essentiale with cholagogue in fatty liver complicated by cholecystitis for lowering the lithogenic properties of bile].
    Vakhrushev IaM; Suchkova EV; Khokhlacheva NA
    Eksp Klin Gastroenterol; 2002; (3):39-41, 119. PubMed ID: 12353386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effectiveness of stachyren in the treatment of patients with chronic cholecystocholangitis].
    Trusov VV; Varfolomeeva TB; Oreshkov TM; Plastinina RA; Sabsaĭ LG
    Vrach Delo; 1972 Nov; 11():66-9. PubMed ID: 4659743
    [No Abstract]   [Full Text] [Related]  

  • 33. Biliary tract infections.
    Ram MD
    J Ky Med Assoc; 1983 Mar; 81(3):167-70. PubMed ID: 6842053
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of biliary tract diseases with Felwiten].
    Gonciarz Z
    Pol Tyg Lek; 1971 Jul; 26(28):1084-6. PubMed ID: 5096682
    [No Abstract]   [Full Text] [Related]  

  • 35. [Xylitol as a choleretic and cholecystokinetic agent].
    Gruncharov V
    Vutr Boles; 1973; 12(2):69-73. PubMed ID: 4713058
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effects of drugs on extrahepatic bile ducts].
    Ritter U
    Med Klin; 1979 Jul; 74(27):1047-52. PubMed ID: 470790
    [No Abstract]   [Full Text] [Related]  

  • 37. Biliary tract emergencies. Endoscopic and medical management.
    Cohen SA; Siegel JH
    Crit Care Clin; 1995 Apr; 11(2):273-94. PubMed ID: 7788532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Imecromone: a new choleretic with antispastic action on Oddi's sphincter. Clinical pharmacology and clinico-statistical study].
    Cremoncini C; Tominz L
    Minerva Med; 1968 Oct; 59(82):4359-68. PubMed ID: 5683717
    [No Abstract]   [Full Text] [Related]  

  • 39. [Personal experiences in the treatment of bile duct diseases using Genebil].
    De Marcos Perez VM
    Rev Esp Enferm Apar Dig; 1969 Nov; 29(4):569-84. PubMed ID: 5363141
    [No Abstract]   [Full Text] [Related]  

  • 40. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.